Sutton, United Kingdom

Vasilios Bavetsias

This inventor holds 4 USPTO granted patents. Top assignee: Btg International Limited. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vasilios Bavetsias. Retrieved from https://idiyas.com/inventor/vasilios-bavetsias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vasilios Bavetsias: Innovator in Anti-Cancer Compounds

Introduction

Vasilios Bavetsias is a notable inventor based in Sutton, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer compounds. With a total of 4 patents to his name, his work is recognized for its therapeutic value.

Latest Patents

His latest patents include innovative cyclopenta[g]quinazoline compounds, which are designed to combat cancer. These compounds feature a complex formula that allows for various substitutions, making them versatile in their application. The therapeutic potential of these compounds lies in their ability to target cancer cells effectively, providing new avenues for treatment.

Career Highlights

Vasilios works at BTG International Limited, where he collaborates with a team of experts to advance research in cancer treatment. His dedication to innovation in this field has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

He collaborates with Ann Lesley Jackman, contributing to the advancement of their shared goals in medicinal research.

Conclusion

Vasilios Bavetsias stands out as an inventor whose work in anti-cancer compounds is paving the way for future advancements in cancer treatment. His contributions are vital to the ongoing fight against this disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…